Skip to main content

Complement Activation in Retinal Degeneration

  • Conference paper
  • First Online:
Retinal Degenerative Diseases

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 723))

Abstract

Our aim is to investigate a common role of the complement system in the pathogenesis of retinal disease, by assessing the expression profile of complement component 3 (C3) in three mechanistically distinct models of retinal degeneration: light-damage, hyperoxia and the degenerative P23H-3 rodent strain. In the light damage model, young adult albino Sprague Dawley (SD) rats were exposed to 1,000 lx for a period of up to 24 h, where at specific time points during and after exposure, animals were euthanized and retinas extracted for analysis. In the hyperoxia model, adult C57 mice were subjected to 75% oxygen for up to 14 days, then euthanized and retinas dissected for analysis. In the genetic model, SD and P23H-3 animals were born and reared until postnatal day 50–130, then euthanized and retinas extracted. For all three models, C3 mRNA expression levels were determined by quantitative PCR (qPCR), while photoreceptor death was quantified using the TUNEL technique. Up-regulation of C3 expression was evident in retinal tissue from all experimental models assessed. C3 expression in light damage showed a marked upregulation after 24 h of exposure, which continued into the post-exposure period. Modest increases in C3 were evident during early hyperoxia, which progressed to a substantial upregulation after 14 days. C3 expression in P23H retinas was consistently higher than those of non-degenerative SD retinas. Upregulation of C3 in all models was associated with substantial increases photoreceptor apoptosis. While the degenerative stimuli in these models differ, the increased expression of C3 in conjunction with increasing photoreceptor death provides evidence for a common pathway in retinal degeneration involving the activation of complement.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Anderson DH, Radeke MJ, Gallo NB et al (2010) The pivotal role of the complement system in aging and age-related macular degeneration: Hypothesis re-visited. Prog Retin Eye Res 29:95–112

    Article  PubMed  CAS  Google Scholar 

  • Despriet DD, van Duijn CM, Oostra BA, et al (2009) Complement component C3 and risk of age-related macular degeneration. Ophthalmology 116:474–480 e472

    Google Scholar 

  • Figueroa E, Gordon LE, Feldhoff PW et al (2005) The administration of cobra venom factor reduces post-ischemic cerebral injury in adult and neonatal rats. Neurosci Lett 380:48–53

    Article  PubMed  CAS  Google Scholar 

  • Gasque P (2004) Complement: a unique innate immune sensor for danger signals. Mol Immunol 41:1089–1098

    Article  PubMed  CAS  Google Scholar 

  • Jakobsdottir J, Conley YP, Weeks DE et al (2008) C2 and CFB genes in age-related maculopathy and joint action with CFH and LOC387715 genes. PLoS One 3:e2199.

    Article  PubMed  Google Scholar 

  • Klein RJ, Zeiss C, Chew EY et al (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308:385–389

    Article  PubMed  CAS  Google Scholar 

  • Rohrer B, Guo Y, Kunchithapautham K et al (2007) Eliminating complement Factor D reduces photoreceptor susceptibility to light-induced damage. Invest Ophthalmol Vis Sci 48:5282–5289

    Article  PubMed  Google Scholar 

  • Trouw LA, Blom AM, Gasque P (2008) Role of complement and complement regulators in the removal of apoptotic cells. Mol Immunol 45:1199–1207

    Article  PubMed  CAS  Google Scholar 

  • Walport MJ (2001) Complement: Second of two parts. N Eng J Med 344:1140–1144

    Article  CAS  Google Scholar 

  • Yang S, Nakamura T, Hua Y et al (2006) The role of complement C3 in intracerebral hemorrhage-induced brain injury. J Cereb Blood Flow Metab 26:1490–1495

    Article  PubMed  CAS  Google Scholar 

  • Yates JR, Sepp T, Matharu BK et al (2007) Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med 357:553–561

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Matt Rutar .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this paper

Cite this paper

Rutar, M., Natoli, R., Provis, J., Valter, K. (2012). Complement Activation in Retinal Degeneration. In: LaVail, M., Ash, J., Anderson, R., Hollyfield, J., Grimm, C. (eds) Retinal Degenerative Diseases. Advances in Experimental Medicine and Biology, vol 723. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-0631-0_5

Download citation

Publish with us

Policies and ethics